Key result
The CS/TA@PAs-Eu hydrogel performed adaptive repair of myocardial infarction to prevent left ventricular remodeling and restore cardiac function in animal models.
Why the study?
Hydrogel-based engineered cardiac patches hold promise for treating myocardial infarction, but optimizing patches with better biocompatibility, mechanical stability, and adaptation to repair remains a challenge.
Does a functionalized chitosan hydrogel (CS/TA@PAs-Eu) improve cardiac function and prevent left ventricular remodeling in animal models of myocardial infarction?
Does a functionalized chitosan hydrogel (CS/TA@PAs-Eu) improve cardiac function and prevent left ventricular remodeling in animal models of myocardial infarction?
A novel functionalized chitosan hydrogel demonstrated potential for adaptive repair of myocardial infarction by improving mitochondrial function, promoting angiogenesis, and preventing LV remodeling in preclinical models.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for post-MI hydrogel repair; leaves open translation and safety in human trials.
Hydrogel‐based engineered cardiac patches (ECP) hold great promise as potential treatment options for myocardial infarction (MI). However, optimizing the preparation of ECP with better biocompatibility, mechanical stability, and adaptation to MI repair remains a challenge. In this study, a chitosan (CS) hydrogel with good mechanical robustness through programmed control of hydrogen bonding is constructed to adapt to the continuous beating of myocardial tissue. With the synergistic effects of lipoic acid (TA), proanthocyanidins (PAs), and Eu 3+ , a functional platform capable of improving mitochondrial function, antioxidation, and pro‐vascularization is further constructed for the adaptive repair of the MI microenvironment. The fabricated functionalized chitosan hydrogel (CS/TA@PAs‐Eu) possessed good mechanical stability and ionic conductivity, showing the potential for long‐term adaptation to myocardial tissue pulsation. Also, the CS/TA@PAs‐Eu hydrogel promoted cardiomyocytes (CMs) maturation and functionalization, and effectively improved mitochondrial function, scavenged reactive oxygen species (ROS) as well as promoted angiogenesis. Animal studies indicated that the CS/TA@PAs‐Eu hydrogel can perform adaptive repair of MI to prevent left ventricular (LV) remodeling and restore cardiac function. This study highlights a functionalized hydrogel ECP with good biocompatibility and mechanical robustness for the adaptive repair of MI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Myocardial infarction. CS/TA@PAs-Eu hydrogel was evaluated on Left ventricular remodeling and cardiac function. The CS/TA@PAs-Eu hydrogel performed adaptive repair of myocardial infarction to prevent left ventricular remodeling and restore cardiac function in animal models.
Synapse has enriched 10 related papers. Consider them for comparative context: